Literature DB >> 4793673

[Growth hormone release in unstable diabetes: tests with saline, arginine, glucagon, and epinephrine (author's transl)].

G M Cremer, G D Molnar, W F Taylor, J W Rosevear, E Ackerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4793673     DOI： 10.1007/bf02590712

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN： 0001-5563


× No keyword cloud information.
  34 in total

1.  Control of growth-hormone secretion in health and disease.

Authors: 
Journal:  Lancet       Date:  1969-01-11       Impact factor: 79.321

2.  Diurnal growth hormone and glucose abnormalities in unstable diabetics: studies of ambulatory-fed subjects during continuous blood glucose analysis.

Authors:  G D Molnar; W F Taylor; A Langworthy; V Fatourechi
Journal:  J Clin Endocrinol Metab       Date:  1972-05       Impact factor: 5.958

3.  Growth hormone and glucose interrelationships in diabetes: studies of inadvertent hypoglycemic episodes during continuous blood glucose analysis.

Authors:  G D Molnar; V Fatourechi; E Ackerman; W F Taylor; J W Rosevear; L C Gatewood; F J Service; K E Moxness
Journal:  J Clin Endocrinol Metab       Date:  1971-03       Impact factor: 5.958

4.  Disappearance of bovine insulin from plasma in diabetic and normal subjects.

Authors:  P J Palumbo; W F Taylor; G D Molnar; W N Tauxe
Journal:  Metabolism       Date:  1972-09       Impact factor: 8.694

5.  Studies of diabetic instability. I. Immunoassay of human insulin in plasma containing antibodies to pork and beef insulin.

Authors:  K E Moxness; G D Molnar; W F Taylor; C A Owen; E Ackerman; J W Rosevear
Journal:  Metabolism       Date:  1971-12       Impact factor: 8.694

6.  The disappearance of labelled human growth hormone from the forearm circulation in normal and diabetic subjects.

Authors:  B J Boucher; W J Butterfield; M J Whichelow
Journal:  Clin Sci       Date:  1969-12       Impact factor: 6.124

7.  Hormonal and biochemical response to glucagon administration in patients with pheochromocytoma and in control subjects.

Authors:  G M Cremer; G D Molnar; K E Moxness; S G Sheps; F T Maher; J D Jones
Journal:  Mayo Clin Proc       Date:  1968-03       Impact factor: 7.616

8.  Continuous blood glucose analysis in ambulatory fed subjects. I. General methodology.

Authors:  G D Molnar; E Ackerman; J W Rosevear; L C Gatewood; K E Moxness
Journal:  Mayo Clin Proc       Date:  1968-12       Impact factor: 7.616

9.  Abnormal serum growth hormone response to exercise in juvenile diabetics.

Authors:  A P Hansen
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

10.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728
View more
  3 in total

1.  Growth hormone response to thyrotropin releasing hormone and placebo in a group of insulin dependent diabetic patients.

Authors:  U Valentini; A Cimino; A Rotondi; L Rocca; R Pelizzari; A Giustina; C Marchetti; G Romanelli
Journal:  J Endocrinol Invest       Date:  1989-10       Impact factor: 4.256

Review 2.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

3.  Variability in the growth hormone response to growth hormone-releasing hormone alone or combined with pyridostigmine in type 1 diabetic patients.

Authors:  A Giustina; C Bodini; S Bossoni; U Valentini; W B Wehrenberg
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.